NCT03397602

Brief Summary

The main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fibrillation. Positive findings are vitally important for these patients, given the condition's substantial morbidity, mortality and high economic costs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
142mo left

Started Jan 2019

Longer than P75 for not_applicable atrial-fibrillation

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2019Dec 2037

First Submitted

Initial submission to the registry

January 4, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 12, 2018

Completed
1 year until next milestone

Study Start

First participant enrolled

January 23, 2019

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2037

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

8.9 years

First QC Date

January 4, 2018

Last Update Submit

March 9, 2026

Conditions

Keywords

atrial fibrillationexercise

Outcome Measures

Primary Outcomes (2)

  • Changes in quality of life measured by the physical component summary (PCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36).

    Changes in quality of life measured by the physical component summary (PCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36) from baseline to 12 weeks.

    baseline to 12 weeks

  • Changes in exercise capacity measured by VO2peak on a symptom-limited cardiopulmonary exercise test (CPET).

    Changes in exercise capacity measured by VO2peak on a symptom-limited cardiopulmonary exercise test (CPET) from baseline to 12 weeks.

    baseline to 12 weeks

Secondary Outcomes (11)

  • Changes atrial fibrillation specific quality of life measured by the Atrial Fibrillation Effect on Quality of Life Questionnaire (AFEQT).

    baseline to 12 weeks

  • Changes atrial fibrillation specific quality of life measured by the University of Toronto Atrial Fibrillation Severity Scale (AFSS).

    baseline to 12 weeks

  • Changes in symptom burden measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation Scale.

    baseline to 12 weeks

  • Changes in quality of life measured by the mental component summary (MCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36).

    baseline to 12 weeks

  • Changes in heart rate control measured by 24-hour Holter ECG recordings and ECG recordings at each CPET.

    baseline to 12 weeks

  • +6 more secondary outcomes

Study Arms (3)

standard care

NO INTERVENTION

Participants do not participate in a on site structured exercise training program.

standard care + MICE

EXPERIMENTAL

standard care + moderate-intensity continuous exercise training (MICE)

Behavioral: standard care + moderate-intensity continuous exercise training

standard care + HIIT

EXPERIMENTAL

standard care + high-intensity interval training (HIIT)

Behavioral: standard care + high-intensity interval training

Interventions

Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.

standard care + MICE

Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.

standard care + HIIT

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persistent or permanent atrial fibrillation;
  • rate controlled with a resting ventricular rate of equal to or less than 100 bpm;
  • able to perform a symptom-limited exercise test;
  • at least 40 years of age (i.e. participants must be 40 years or older);

You may not qualify if:

  • currently participating in routine exercise training (more than two times per week);
  • unstable angina;
  • diagnosed severe mitral or aortic stenosis;
  • diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction;
  • pregnant, lactating or planning to become pregnant during the study period;
  • unable to provide written, informed consent, or
  • unwilling or unable to return for follow up at week 12.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

London Health Sciences Network

London, Ontario, Canada

RECRUITING

University of Ottawa Heart Insititue

Ottawa, Ontario, K1Y 4W7, Canada

RECRUITING

MeSH Terms

Conditions

Atrial FibrillationMotor Activity

Interventions

Standard of CareHigh-Intensity Interval Training

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jennifer L Reed, PhD

    Ottawa Heart Institute Research Corporation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer L Reed, PhD

CONTACT

Matheus Mistura, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2018

First Posted

January 12, 2018

Study Start

January 23, 2019

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

December 30, 2037

Last Updated

March 11, 2026

Record last verified: 2026-03

Locations